Proteome‐based classification of Nonmuscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Proteome‐based classification of Nonmuscle Invasive Bladder Cancer

Published:2019-07-26 Issue:1 Volume:146 Page:281-294
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Stroggilos Rafael¹^ORCID,Mokou Marika¹,Latosinska Agnieszka²,Makridakis Manousos¹,Lygirou Vasiliki¹,Mavrogeorgis Emmanouil³,Drekolias Dimitrios⁴,Frantzi Maria²,Mullen William⁵,Fragkoulis Charalampos⁶,Stasinopoulos Konstantinos⁶,Papadopoulos Georgios⁶,Stathouros Georgios⁶,Lazaris Andreas C.⁴,Makrythanasis Periklis¹⁷,Ntoumas Konstantinos⁶,Mischak Harald²⁵,Zoidakis Jerome¹,Vlahou Antonia¹

Affiliation:

1. Biotechnology DivisionBiomedical Research Foundation of the Academy of Athens Athens Greece

2. Mosaiques Diagnostics GmbH Hannover Germany

3. Department of BiotechnologyAgricultural University of Athens Athens Greece

4. Department of Pathology, School of MedicineNational and Kapodistrian University of Athens Athens Greece

5. British Heart Foundation Glasgow Cardiovascular Research CentreUniversity of Glasgow Glasgow United Kingdom

6. Department of UrologyGeneral Hospital of Athens ‘Georgios Gennimatas’ Athens Greece

7. Department of Genetic Medicine and DevelopmentUniversity of Geneva Geneva Switzerland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32556

Reference59 articles.

1. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

2. Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

3. A Molecular Taxonomy for Urothelial Carcinoma

4. Comprehensive molecular characterization of urothelial bladder carcinoma

5. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic analysis of the urothelial cancer landscape;Nature Communications;2024-05-27

2. Expression of LASS2 Can be Regulated by Dihydroartemisinin to Regulate Cisplatin Chemosensitivity in Bladder Cancer Cells;Current Pharmaceutical Biotechnology;2024-05-16

3. Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy;2024-05-02

4. Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer;Biomedicine & Pharmacotherapy;2024-04

5. Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of high-grade T1 bladder cancer;International Urology and Nephrology;2024-03-26